SCHEMBL13961674

SCHEMBL13961674

Bc1cc(C(C)(C)O)c2ncn(COCC[Si](C)(C)C)c2c1

nearest known ligand 0.32

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ DGAT1 O75907 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2422457 0.86 DGAT1 (0.36) DGAT1
SCHEMBL13961677 0.79 TSHR (0.34) —
SCHEMBL13961680 0.79 — —
SCHEMBL13961673 0.76 DGAT1 (0.36) DGAT1
SCHEMBL13961678 0.74 — —
SCHEMBL31337206 0.72 DGAT1 (0.39) DGAT1
SCHEMBL30897298 0.71 DGAT1 (0.41) DGAT1
SCHEMBL27250977 0.71 DGAT1 (0.41) DGAT1
SCHEMBL2143567 0.70 PRPS1 (0.38) DGAT1
SCHEMBL12289551 0.69 DGAT1 (0.35) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009009411-A1 SUBSTITUTED HETEROCYCLIC ETHERS AND THEIR USE IN CNS DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 2009-01-15 — — WO disclosed
Send feedback